Equillium
IPOPublic · San Diego, United States · Founded 2017
- Headquarters
- San Diego
- Founded
- 2017
- Business Model
- B2B
- Website
- equilliumbio.com
- Type
- Public
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Equillium is a clinical-stage biotechnology company that leverages a deep understanding of immunobiology to develop novel therapeutics for severe autoimmune and inflammatory diseases with high unmet medical need. Headquartered in San Diego, its pipeline includes EQ504, a selective AhR modulator, and a proprietary multi-cytokine inhibitor platform of structured-domain peptides designed to selectively inhibit multiple disease-driving cytokines.
Summary
Equillium is a Biotech company based in San Diego, United States, founded in 2017.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Oct 2018
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/equillium"><img src="https://indexed.vc/api/badge/company/equillium" alt="Equillium on Indexed.vc" width="260" height="76" /></a>